Status:
TERMINATED
Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care
Lead Sponsor:
University Hospital, Geneva
Conditions:
Cancer
Venous Thromboembolism
Eligibility:
All Genders
Brief Summary
To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care
Eligibility Criteria
Inclusion
- Cancer patients in palliative care
- Patients fully informed about their condition
- Signed informed consent
- No exclusion criteria
Exclusion
- Absence of advanced cancer
- Cancer previously cured
- Venous thromboembolism diagnosed within 6 months prior to inclusion
- Absence of discerning capacity
- Active anti-thrombotic treatment with heparins or coumarines
- Thrombocytopenia \<50G/l
- PTT \>45sec
- TP\<35%
- Active bleeding
- Renal failure \<20ml/min
- Past history of heparin-induced thrombocytopenia
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
End Date :
July 1 2002
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00303407
Start Date
January 1 2001
End Date
July 1 2002
Last Update
March 16 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of Continuous Care, chemin de la Savonnière
Collonge-Bellerive (Geneva), Canton of Geneva, Switzerland, 1245